Role of NT-proBNP in acute heart failure diagnosis and treatment.

Back

HFA Premium Access

Role of NT-proBNP in acute heart failure diagnosis and treatment.

Session: How heart failure biomarkers change clinical practice in the management of acute heart failure

Topic: Biomarkers

Speaker: Doctor H. Gaggin (Boston, US)

About the speaker

Doctor Hanna Gaggin

Massachusetts General Hospital, Boston (United States of America)

2 presentations

0 follower

3 more presentations in this session

Physiologic differences between BNP and NT-proBNP and impact on clinical practice.

Speaker: Professor D. Logeart (Paris, FR)

Access

Optimization of post-discharge management after acute heart failure.

Speaker: Professor R. Troughton (Christchurch, NZ)

Access

Faculty discussion - How heart failure biomarkers change clinical practice in the management of acute heart failure.

Speaker: Professor A. Mebazaa (Paris, FR) Professor H. Brunner-La Rocca (Maastricht, NL) Doctor H. Gaggin (Boston, US) Professor D. Logeart (Paris, FR) Professor R. Troughton (Christchurch, NZ)

Access

Access the full session

How heart failure biomarkers change clinical practice in the management of acute heart failure

Speakers: Doctor H. Gaggin, Professor D. Logeart, Professor R. Troughton, Professor A. Mebazaa, Professor H. Brunner-La Rocca...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources